Krystal Biotech initiated with an Outperform at RBC Capital
very_bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
very_bullish
What happened, with direct paths to the underlying reporting
Outperform initiation; target $400; current price $328.34; priceChangeSinceSignal 1.2
Target: $400
Posted price: $328.34
Analyst firm: RBC Capital
Analyst: Lisa Walter
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.